Suppr超能文献

同种异体造血干细胞移植后儿童肾并发症的病理评估:一项回顾性队列研究。

Pathological evaluation of renal complications in children following allogeneic hematopoietic stem cell transplantation: a retrospective cohort study.

机构信息

Department of Nephrology and Immunology, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.

Department of Hematology, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.

出版信息

BMC Pediatr. 2023 Apr 21;23(1):186. doi: 10.1186/s12887-023-03996-1.

Abstract

BACKGROUND

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative therapy for hematologic malignancies and non-malignant disorders, such as aplastic anemia, fanconi anemia, and certain immune deficiencies. Post-transplantation kidney injury is a common complication and involves a wide spectrum of structural abnormalities, including glomerular (MSPGN, mesangial proliferative glomerulonephritis; FSGS, focal segmental glomerulosclerosis; MPGN, membranoproliferative glomerulonephritis; MCD, minimal change disease), vascular (TMA, thrombotic microangiopathy), and/or tubulointerstitial (TIN, tubulointerstitial nephritis; ATI, acute tubular injury). Renal biopsy is the gold-standard examination for defining multiple etiologies of kidney impairment. Although kidney injury following HSCT has been studied, little is known about the effects of allo-HSCT on renal pathology in pediatric patients.

METHODS

We retrospectively analyzed renal biopsy specimens from children with kidney injury after allo-HSCT and correlated results with clinical data in the last 10 years.

RESULTS

Among 25 children (18 males and 7 females), three patients had proteinuria indicating nephrotic syndrome (24-hour urinary total protein/weight > 50 mg/kg/d), nine patients had severely reduced estimated glomerular filtration rate (eGFR < 30 ml/min/1.73 m) and four patients received kidney replacement therapy (KRT). The main pathologies identified from kidney biopsies were MSPGN (n = 12), FSGS (n = 12), MPGN (n = 5), TMA (n = 4), MCD (n = 3), diffuse glomerular fibrosis (DGF, n = 2), ATI and TIN, in isolation or combined with other pathologies. The median follow-up time was 16.5 (0.5 ~ 68.0) months. Three patients died of recurrent malignancy and/or severe infection, one child developed to end-stage renal disease (ESRD), six patients (24%) had elevated serum creatinine (SCr > 100µmol/l) and nine patients (36%) still had proteinuria.

CONCLUSIONS

This study evaluates histomorphologic findings from kidney biopsies of pediatric recipients following allo-HSCT. Detailed evaluation of renal biopsy samples is helpful to elucidate the nature of renal insult, and may potentially identify treatable disease processes.

摘要

背景

异基因造血干细胞移植(allo-HSCT)是治疗血液系统恶性肿瘤和非恶性疾病的一种有治愈可能的疗法,例如再生障碍性贫血、范可尼贫血和某些免疫缺陷。移植后肾脏损伤是一种常见的并发症,涉及广泛的结构异常,包括肾小球(MSPGN、系膜增生性肾小球肾炎;FSGS、局灶节段性肾小球硬化;MPGN、膜增生性肾小球肾炎;MCD、微小病变病)、血管(TMA、血栓性微血管病)和/或肾小管间质(TIN、肾小管间质性肾炎;ATI、急性肾小管损伤)。肾脏活检是确定肾脏损伤多种病因的金标准检查。尽管已经研究了 HSCT 后肾脏损伤,但对于 allo-HSCT 对儿科患者肾脏病理的影响知之甚少。

方法

我们回顾性分析了 10 年来接受 allo-HSCT 后发生肾脏损伤的儿童的肾脏活检标本,并将结果与临床数据相关联。

结果

在 25 名儿童(18 名男性和 7 名女性)中,3 名患者出现蛋白尿提示肾病综合征(24 小时尿总蛋白/体重>50mg/kg/d),9 名患者肾小球滤过率严重降低(eGFR<30ml/min/1.73m),4 名患者接受肾脏替代治疗(KRT)。肾脏活检的主要病理改变为 MSPGN(n=12)、FSGS(n=12)、MPGN(n=5)、TMA(n=4)、MCD(n=3)、弥漫性肾小球纤维化(DGF,n=2)、孤立或合并其他病理改变的 ATI 和 TIN。中位随访时间为 16.5(0.5~68.0)个月。3 名患者死于复发性恶性肿瘤和/或严重感染,1 名儿童发展为终末期肾病(ESRD),6 名患者(24%)血清肌酐(SCr>100μmol/l)升高,9 名患者(36%)仍有蛋白尿。

结论

本研究评估了 allo-HSCT 后儿科受者肾脏活检的组织形态学发现。详细评估肾脏活检样本有助于阐明肾脏损伤的性质,并可能确定可治疗的疾病过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d78/10120150/8be649c99e97/12887_2023_3996_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验